Biotech IPOs near last year's pace, despite COVID-19 pandemic

Biotech IPOs near last year's pace, despite COVID-19 pandemic

Source: 
BioPharma Dive
snippet: 

Pliant's IPO keeps biotech close to its 2019 pace, a telling statistic given the coronavirus pandemic has thrown public markets into turmoil since early March. IPO activity has shown signs of picking up, too, with multiple biotechs either recently filing offerings or closing in on pricing them. Chinese firm Legend Biotech could hold the sector's biggest IPO of the year on Thursday.